Biomay AG
Records under this name other than the patents Biomay AG holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,296,828 | Vaccine carrier Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 11,020,477 | RNA Vaccines Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 9,308,251 | Peptide carrier fusion proteins as allergy vaccines Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,844,591 | Peptide carrier fusion proteins as allergy vaccines Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,209,257 | Solid Support Comprising HIV-1 Clade C Envelope Peptides for the Detection of HIV-1-Specific Antibodies Formerly held In force · High confidence | In force | High confidence | |
| US 11,926,651 | Polypeptide construct comprising fragments of allergens Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 11,237,166 | Method for detecting HIV-1-specific antibodies using clade C env polypeptides Formerly held Lapsed on the fee record Ended Feb 1, 2026 · From the USPTO record | Lapsed on the fee record | Ended Feb 1, 2026 | From the USPTO record |
| US 9,638,694 | Method for diagnosing a rhinovirus infection Formerly held Lapsed on the fee record Ended May 2, 2025 · From the USPTO record | Lapsed on the fee record | Ended May 2, 2025 | From the USPTO record |
| US 9,360,486 | Allergen fragments Lapsed on the fee record Ended Jun 7, 2024 · From the USPTO record | Lapsed on the fee record | Ended Jun 7, 2024 | From the USPTO record |
| US 9,040,054 | Hypoallergenic molecules Lapsed on the fee record Ended May 26, 2023 · From the USPTO record | Lapsed on the fee record | Ended May 26, 2023 | From the USPTO record |